Search the collection

5 results for Pristupa,+Alexander+S.

Sort by:

Sort by

Limit results to:

20 per page

5 results for Pristupa,+Alexander+S.

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, pl...
Author / Creator:Zelenetz, Andrew D, Prof ; Barrientos, Jacqueline C, MD ; Brown, Jennifer R, MD ; Coiffier, Bertrand, Prof ; Delgado, Julio, MD ; Egyed, Miklós, Prof ; Ghia, Paolo, MD ; Illés, Árpád, Prof ; Jurczak, Wojciech, MD ; Marlton, Paula, MBBS ; Montillo, Marco, MD ; Morschhauser, Franck, Prof ; Pristupa, Alexander S, MD ; Robak, Tadeusz, Prof ; Sharman, Jeff P, MD ; Simpson, David, MBChB ; Smolej, Lukáš, MD ; Tausch, Eugen, MD ; Adewoye, Adeboye H, MD ; Dreiling, Lyndah K, MD ; Kim, Yeonhee, PhD ; Stilgenbauer, Stephan, Prof ; Hillmen, Peter, Prof
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2017-03, Vol.18 (3), p.297-311
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: results of a phase 3, randomized, controlled trial
Author / Creator:Montillo, Marco ; Illés, Árpád ; Robak, Tadeusz ; Pristupa, Alexander S ; Wach, Malgorzata ; Egyed, Miklós ; Delgado, Julio ; Jurczak, Wojciech ; Morschhauser, Franck ; Schuh, Anna ; Eradat, Herbert ; Shreay, Sanatan ; Barrientos, Jacqueline C ; Zelenetz, Andrew D
Publisher:England: BioMed Central Ltd
Journal title:Health and quality of life outcomes, 2019-11, Vol.17 (1), p.173-173, Article 173
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
ArticlesPeer ReviewedFull Text
Idelalisib or Placebo in Combination with Bendamustine and Rituximab in Patients with Relapsed/Refractory CLL - Interim Results of a Phase 3 Randomized, Double-blind Placebo-Controlled Trial
Author / Creator:Zelenetz, Andrew D. ; Barrientos, Jacqueline C. ; Brown, Jennifer R. ; Coiffier, Bertrand ; Delgado, Julio ; Egyed, Miklós ; Ghia, Paolo ; Illés, Árpád ; Jurczak, Wojciech ; Marlton, Paula ; Montillo, Marco ; Morschhauser, Franck ; Pristupa, Alexander S. ; Robak, Tadeusz ; Sharman, Jeff P. ; Simpson, David ; Smolej, Lukáš ; Tausch, Eugen ; Adewoye, Adeboye H. ; Dreiling, Lyndah K. ; Kim, Yeonhee ; Stilgenbauer, Stephan ; Hillmen, Peter
Journal title:The lancet oncology, 2017-01, Vol.18 (3), p.297-311
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 4
ArticlesPeer ReviewedFull Text
Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
Author / Creator:Palumbo, Antonio ; Chanan-Khan, Asher ; Weisel, Katja ; Nooka, Ajay K ; Masszi, Tamas ; Beksac, Meral ; Spicka, Ivan ; Hungria, Vania ; Munder, Markus ; Mateos, Maria V ; Mark, Tomer M ; Qi, Ming ; Schecter, Jordan ; Amin, Himal ; Qin, Xiang ; Deraedt, William ; Ahmadi, Tahamtan ; Spencer, Andrew ; Sonneveld, Pieter
Publisher:United States: Massachusetts Medical Society
Journal title:The New England journal of medicine, 2016-08, Vol.375 (8), p.754-766
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 5
ArticlesPeer ReviewedFull Text
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
Author / Creator:Burger, Jan A ; Tedeschi, Alessandra ; Barr, Paul M ; Robak, Tadeusz ; Owen, Carolyn ; Ghia, Paolo ; Bairey, Osnat ; Hillmen, Peter ; Bartlett, Nancy L ; Li, Jianyong ; Simpson, David ; Grosicki, Sebastian ; Devereux, Stephen ; McCarthy, Helen ; Coutre, Steven ; Quach, Hang ; Gaidano, Gianluca ; Maslyak, Zvenyslava ; Stevens, Don A ; Janssens, Ann ; Offner, Fritz ; Mayer, Jiří ; O’Dwyer, Michael ; Hellmann, Andrzej ; Schuh, Anna ; Siddiqi, Tanya ; Polliack, Aaron ; Tam, Constantine S ; Suri, Deepali ; Cheng, Mei ; Clow, Fong ; Styles, Lori ; James, Danelle F ; Kipps, Thomas J
Publisher:United States: Massachusetts Medical Society
Journal title:The New England journal of medicine, 2015-12, Vol.373 (25), p.2425-2437
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Export record to excel

Export this record

Export record to excel

Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, pl...

Export this record

Export record to excel

Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: results of a phase 3, randomized, controlled trial

Export this record

Export record to excel

Idelalisib or Placebo in Combination with Bendamustine and Rituximab in Patients with Relapsed/Refractory CLL - Interim Results of a Phase 3 Randomized, Double-blind Placebo-Controlled Trial

Export this record

Export record to excel

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma

Export this record

Export record to excel

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia

Refine your search